Eli Lilly and Company Profile (NYSE:LLY)

About Eli Lilly and

Eli Lilly and logoEli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LLY
  • CUSIP: 53245710
Key Metrics:
  • Previous Close: $77.75
  • 50 Day Moving Average: $79.79
  • 200 Day Moving Average: $78.11
  • 52-Week Range: $67.88 - $88.16
  • Trailing P/E Ratio: 33.51
  • Foreward P/E Ratio: 18.95
  • P/E Growth: 1.81
  • Market Cap: $82.24B
  • Outstanding Shares: 1,057,699,000
  • Beta: 0.17
  • Net Margins: 11.97%
  • Return on Equity: 23.99%
  • Return on Assets: 9.98%
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 1.54%
  • Quick Ratio: 1.10%
Additional Links:
Companies Related to Eli Lilly and:

Analyst Ratings

Consensus Ratings for Eli Lilly and (NYSE:LLY) (?)
Ratings Breakdown: 2 Hold Ratings, 16 Buy Ratings
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: $98.24 (27.98% upside)

Analysts' Ratings History for Eli Lilly and (NYSE:LLY)
DateFirmActionRatingPrice TargetDetails
10/9/2016Leerink SwannReiterated RatingBuy$103.00View Rating Details
10/3/2016BMO Capital MarketsReiterated RatingBuy$94.00View Rating Details
9/27/2016Goldman Sachs Group Inc.UpgradeNeutral -> Buy$89.00 -> $95.00View Rating Details
9/20/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
9/14/2016Jefferies GroupReiterated RatingBuy$105.00View Rating Details
9/8/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$92.00 -> $95.00View Rating Details
8/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/2/2016ArgusBoost Price TargetBuy$90.00 -> $95.00View Rating Details
7/6/2016Credit Suisse Group AGReiterated RatingBuy$91.00View Rating Details
6/15/2016SunTrust Banks Inc.Reiterated RatingBuyView Rating Details
6/4/2016Morgan StanleyReiterated RatingHold$88.00View Rating Details
4/6/2016Societe GeneraleInitiated CoverageHold$78.00View Rating Details
2/4/2016Berenberg BankBoost Price TargetBuy$105.00 -> $106.00View Rating Details
1/29/2016Sanford C. BernsteinLower Price TargetOutperform$93.00 -> $92.00View Rating Details
12/22/2015Bank of America Corp.Reiterated RatingBuy$104.00 -> $108.00View Rating Details
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$100.00View Rating Details
12/9/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
12/1/2015Barclays PLCUpgradeEqual Weight -> Overweight$75.00 -> $95.00View Rating Details
8/21/2015Cowen and CompanyReiterated RatingOutperform$92.00View Rating Details
2/23/2015Tigress FinancialReiterated RatingBuyView Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Eli Lilly and (NYSE:LLY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016Q316$0.96$0.88$4.23 billion$5.19 billionViewListenView Earnings Details
7/26/2016Q216$0.86$0.86$5.14 billion$5.40 billionViewListenView Earnings Details
4/26/2016Q116$0.85$0.83$4.82 billion$4.87 billionViewListenView Earnings Details
1/28/2016Q415$0.78$0.78$5.33 billion$5.38 billionViewListenView Earnings Details
10/22/2015Q315$0.76$0.89$4.99 billion$4.96 billionViewListenView Earnings Details
7/23/2015Q215$0.74$0.90$4.89 billion$4.98 billionViewListenView Earnings Details
4/23/2015Q115$0.76$0.87$4.62 billion$4.64 billionViewN/AView Earnings Details
1/30/2015Q414$0.74$0.75$5.21 billion$5.12 billionViewN/AView Earnings Details
10/23/2014Q314$0.67$0.66$4.83 billion$4.88 billionViewListenView Earnings Details
7/24/2014Q214$0.65$0.68$4.88 billion$4.94 billionViewN/AView Earnings Details
4/24/2014Q114$0.70$0.70$4.78 billion$4.68 billionViewN/AView Earnings Details
1/30/2014Q413$0.72$0.74$5.46 billion$5.81 billionViewListenView Earnings Details
10/23/2013Q313$1.04$1.11$5.76 billion$5.77 billionViewN/AView Earnings Details
7/24/2013Q2 2013$1.01$1.16$5.82 billion$5.93 billionViewN/AView Earnings Details
4/24/2013Q1 2013$1.05$1.14$5.66 billion$5.60 billionViewN/AView Earnings Details
1/29/2013Q4 2012$0.82$0.85$5.78 billion$5.96 billionViewN/AView Earnings Details
10/24/2012$0.82$0.79ViewN/AView Earnings Details
7/25/2012$0.76$0.83ViewN/AView Earnings Details
4/25/2012$0.80$0.92ViewN/AView Earnings Details
1/31/2012$0.80$0.87ViewN/AView Earnings Details
10/20/2011$1.12$1.13ViewN/AView Earnings Details
7/21/2011$1.18$1.18ViewN/AView Earnings Details
4/18/2011$1.16$1.24ViewN/AView Earnings Details
1/27/2011$1.10$1.11ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Eli Lilly and (NYSE:LLY)
Current Year EPS Consensus Estimate: $3.59 EPS
Next Year EPS Consensus Estimate: $4.05 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.80$0.86$0.83
Q2 20163$0.85$0.88$0.86
Q3 20163$0.90$0.98$0.93
Q4 20162$0.95$1.03$0.99
(Data provided by Zacks Investment Research)


Current Dividend Information for Eli Lilly and (NYSE:LLY)
Annual Dividend:$2.04
Dividend Yield:2.66%
Dividend Growth:0.70% (3 Year Average)
Payout Ratio:87.93% (Based on Trailing 12 Months of Earnings)
56.82% (Based on Current Year Consensus EPS Estimate)
50.37% (Based on Next Year Consensus EPS Estimate)

Dividend History for Eli Lilly and (NYSE:LLY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Eli Lilly and (NYSE:LLY)
Insider Ownership Percentage: 0.20%
Institutional Ownership Percentage: 74.84%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/5/2016Maria A CroweInsiderSell2,248$81.37$182,919.76View SEC Filing  
8/15/2016Jackson P TaiDirectorBuy5,773$80.43$464,322.39View SEC Filing  
8/12/2016Jackson P TaiDirectorBuy2,560$80.42$205,875.20View SEC Filing  
7/29/2016Lilly Endowment IncMajor ShareholderSell205,000$82.94$17,002,700.00View SEC Filing  
7/28/2016Donald A ZakrowskiInsiderSell1,213$83.16$100,873.08View SEC Filing  
7/28/2016Lilly Endowment IncMajor ShareholderSell240,000$82.87$19,888,800.00View SEC Filing  
7/12/2016Lilly Endowment IncMajor ShareholderSell210,000$79.54$16,703,400.00View SEC Filing  
7/7/2016Lilly Endowment IncMajor ShareholderSell225,000$79.14$17,806,500.00View SEC Filing  
6/30/2016Lilly Endowment IncMajor ShareholderSell215,000$78.46$16,868,900.00View SEC Filing  
6/29/2016Lilly Endowment IncMajor ShareholderSell220,000$77.86$17,129,200.00View SEC Filing  
6/10/2016Melissa S BarnesSVPSell992$73.77$73,179.84View SEC Filing  
5/31/2016Lilly Endowment IncMajor ShareholderSell200,000$75.12$15,024,000.00View SEC Filing  
5/12/2016Jackson P TaiDirectorBuy1,080$75.75$81,810.00View SEC Filing  
5/12/2016Lilly Endowment IncMajor ShareholderSell190,000$75.86$14,413,400.00View SEC Filing  
5/2/2016Donald A ZakrowskiCAOSell1,600$75.86$121,376.00View SEC Filing  
4/29/2016Lilly Endowment IncMajor ShareholderSell180,000$75.44$13,579,200.00View SEC Filing  
4/27/2016Alfonso G ZuluetaSVPSell12,000$76.27$915,240.00View SEC Filing  
4/8/2016Lilly Endowment IncMajor ShareholderSell200,000$74.29$14,858,000.00View SEC Filing  
2/5/2016Stephen F FrySVPSell15,230$78.87$1,201,190.10View SEC Filing  
2/3/2016David A. RicksSVPSell5,733$77.66$445,224.78View SEC Filing  
2/3/2016Derica W. RiceCFOSell10,483$77.78$815,367.74View SEC Filing  
2/1/2016Jackson P TaiDirectorBuy3,170$78.62$249,225.40View SEC Filing  
1/29/2016Alfonso G ZuluetaSVPSell5,000$78.75$393,750.00View SEC Filing  
12/21/2015Lilly Endowment IncMajor ShareholderSell205,000$86.00$17,630,000.00View SEC Filing  
12/15/2015Lilly Endowment IncMajor ShareholderSell215,000$85.60$18,404,000.00View SEC Filing  
12/9/2015Enrique A ConternoVPSell25,000$83.88$2,097,000.00View SEC Filing  
12/2/2015Lilly Endowment Incmajor shareholderSell210,000$85.09$17,868,900.00View SEC Filing  
11/20/2015Lilly Endowment Incmajor shareholderSell205,000$84.54$17,330,700.00View SEC Filing  
10/29/2015Lilly Endowment Incmajor shareholderSell200,000$82.28$16,456,000.00View SEC Filing  
10/9/2015Lilly Endowment Incmajor shareholderSell215,000$85.86$18,459,900.00View SEC Filing  
10/5/2015Lilly Endowment Incmajor shareholderSell260,000$86.46$22,479,600.00View SEC Filing  
9/18/2015Lilly Endowment Incmajor shareholderSell250,000$89.04$22,260,000.00View SEC Filing  
6/10/2015Lilly Endowment IncMajor ShareholderSell210,000$82.39$17,301,900.00View SEC Filing  
6/4/2015Lilly Endowment IncMajor ShareholderSell200,000$77.90$15,580,000.00View SEC Filing  
5/29/2015Jeffrey N SimmonsSVPSell20,000$78.08$1,561,600.00View SEC Filing  
5/20/2015Lilly Endowment IncMajor ShareholderSell190,000$73.43$13,951,700.00View SEC Filing  
5/15/2015Lilly Endowment IncMajor ShareholderSell200,000$72.83$14,566,000.00View SEC Filing  
5/8/2015Lilly Endowment IncMajor ShareholderSell195,000$73.28$14,289,600.00View SEC Filing  
5/1/2015Lilly Endowment IncMajor ShareholderSell200,000$73.09$14,618,000.00View SEC Filing  
3/30/2015Lilly Endowment IncMajor ShareholderSell180,000$73.94$13,309,200.00View SEC Filing  
3/23/2015Lilly Endowment IncMajor ShareholderSell190,000$76.97$14,624,300.00View SEC Filing  
3/9/2015Stephen F FrySVPSell4,000$69.27$277,080.00View SEC Filing  
2/4/2015David A RicksSVPSell3,147$69.99$220,258.53View SEC Filing  
2/4/2015Derica W RiceCFOSell5,316$70.00$372,120.00View SEC Filing  
2/4/2015Jan M LundbergEVPSell11,085$70.08$776,836.80View SEC Filing  
2/3/2015Jan M LundbergEVPSell121,711$70.78$8,614,704.58View SEC Filing  
2/2/2015David A RicksSVPSell4,769$71.51$341,031.19View SEC Filing  
2/2/2015Derica W RiceCFOSell10,068$71.84$723,285.12View SEC Filing  
12/4/2014Lilly Endowment IncMajor ShareholderSell190,000$71.92$13,664,800.00View SEC Filing  
12/2/2014Lilly Endowment IncMajor ShareholderSell180,000$70.14$12,625,200.00View SEC Filing  
11/13/2014Lilly Endowment IncMajor ShareholderSell200,000$67.73$13,546,000.00View SEC Filing  
11/5/2014Lilly Endowment IncMajor ShareholderSell180,000$67.00$12,060,000.00View SEC Filing  
11/4/2014Fionnuala M WalshSVPSell15,000$67.00$1,005,000.00View SEC Filing  
11/3/2014Enrique A ConternoVPSell5,000$66.03$330,150.00View SEC Filing  
10/31/2014Fionnuala M WalshSVPSell7,376$66.58$491,094.08View SEC Filing  
10/31/2014Lilly Endowment IncMajor ShareholderSell190,000$66.40$12,616,000.00View SEC Filing  
10/30/2014Lilly Endowment IncMajor ShareholderSell175,000$66.58$11,651,500.00View SEC Filing  
10/24/2014Maria A CroweInsiderSell2,750$65.77$180,867.50View SEC Filing  
10/6/2014Lilly Endowment IncMajor ShareholderSell210,000$65.63$13,782,300.00View SEC Filing  
10/1/2014Enrique A ConternoVPSell5,000$64.86$324,300.00View SEC Filing  
9/30/2014Lilly Endowment IncMajor ShareholderSell200,000$65.07$13,014,000.00View SEC Filing  
9/10/2014Lilly Endowment IncMajor ShareholderSell210,000$64.77$13,601,700.00View SEC Filing  
9/3/2014Lilly Endowment IncMajor ShareholderSell200,000$63.99$12,798,000.00View SEC Filing  
9/2/2014Enrique A ConternoVPSell5,000$63.60$318,000.00View SEC Filing  
7/29/2014Lilly Endowment IncMajor ShareholderSell250,000$63.03$15,757,500.00View SEC Filing  
7/28/2014Susan MahonySVPSell2,065$63.30$130,714.50View SEC Filing  
7/25/2014Enrique A ConternoVPSell10,000$63.79$637,900.00View SEC Filing  
7/25/2014Susan MahonySVPSell30,000$63.90$1,917,000.00View SEC Filing  
7/1/2014Lilly Endowment IncMajor ShareholderSell235,000$62.30$14,640,500.00View SEC Filing  
6/25/2014Lilly Endowment IncMajor ShareholderSell245,000$62.68$15,356,600.00View SEC Filing  
6/20/2014Lilly Endowment IncMajor ShareholderSell230,000$61.55$14,156,500.00View SEC Filing  
6/16/2014Lilly Endowment IncMajor ShareholderSell200,000$58.73$11,746,000.00View SEC Filing  
6/5/2014Lilly Endowment IncMajor ShareholderSell190,000$59.53$11,310,700.00View SEC Filing  
5/21/2014Lilly Endowment Incmajor shareholderSell230,000$58.90$13,547,000.00View SEC Filing  
5/12/2014Jackson TaiDirectorBuy17,157$59.19$1,015,522.83View SEC Filing  
5/12/2014Lilly Endowment Incmajor shareholderSell210,000$59.33$12,459,300.00View SEC Filing  
5/6/2014Lilly Endowment Incmajor shareholderSell190,000$58.79$11,170,100.00View SEC Filing  
4/29/2014Lilly Endowment Incmajor shareholderSell200,000$59.43$11,886,000.00View SEC Filing  
4/28/2014Lilly Endowment Incmajor shareholderSell150,000$58.64$8,796,000.00View SEC Filing  
8/15/2013Enrique ConternoVPSell5,000$53.79$268,950.00View SEC Filing  
7/29/2013Jacques TapieroSVPSell7,500$53.74$403,050.00View SEC Filing  
7/15/2013Enrique A ConternoVPSell5,000$51.43$257,150.00View SEC Filing  
6/17/2013Enrique A ConternoVPSell5,000$52.45$262,250.00View SEC Filing  
5/15/2013Enrique A ConternoVPSell5,000$56.15$280,750.00View SEC Filing  
5/10/2013Jeffrey N SimmonsSVPSell10,000$54.49$544,900.00View SEC Filing  
3/26/2013Susan MahonySVPSell5,000$56.00$280,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Eli Lilly and (NYSE:LLY)
investorplace.com logo3 Big Pharma Stocks That Are Looking a Little Pale (NYSE:LLY)
investorplace.com - October 26 at 3:00 PM
feeds.benzinga.com logoFollowing Q3 Results, Here's Where Eli Lilly Investors' Focus Is Turning (NYSE:LLY)
feeds.benzinga.com - October 26 at 1:45 PM
fool.com logoBetter Buy: GlaxoSmithKline plc vs. Eli Lilly and Company - Motley Fool (NYSE:LLY)
www.fool.com - October 26 at 9:17 AM
forbes.com logoWays to More Affordable Medicines: Introduction (NYSE:LLY)
www.forbes.com - October 26 at 9:17 AM
bloomberg.com logoLilly Profit Misses Estimates on Low Sales of Treatments - Bloomberg (NYSE:LLY)
www.bloomberg.com - October 25 at 10:59 AM
News IconMerck & Co., Inc. Surges After Earnings, Eli Lilly and Co Slips - ValueWalk (NYSE:LLY)
www.valuewalk.com - October 25 at 10:59 AM
nasdaq.com logoEli Lilly And Co. Q3 Profit Declines 2% - Nasdaq (NYSE:LLY)
www.nasdaq.com - October 25 at 10:59 AM
finance.yahoo.com logoEli Lilly CEO: We're Pleased With Our 3Q Performance (NYSE:LLY)
finance.yahoo.com - October 25 at 10:59 AM
finance.yahoo.com logoLilly (LLY) Misses on Q3 Earnings, Sales; Animal Health Hurts (NYSE:LLY)
finance.yahoo.com - October 25 at 10:59 AM
investors.com logoMerck Crushes Q3 Expectations Following Lung Cancer Drug Win (NYSE:LLY)
www.investors.com - October 25 at 10:59 AM
finance.yahoo.com logoStock Market News for October 25, 2016 (NYSE:LLY)
finance.yahoo.com - October 25 at 10:59 AM
thestreet.com logoJim Cramer -- Merck, Lilly Pressured by Political Uncertainty (NYSE:LLY)
www.thestreet.com - October 25 at 10:59 AM
investors.com logoEli Lilly Q3 Revenue, EPS Miss; CEO Praises Drug Pipeline (NYSE:LLY)
www.investors.com - October 25 at 10:59 AM
marketrealist.com logoHow Much Is the Return Opportunity for Novo Nordisk in 3Q16? (NYSE:LLY)
marketrealist.com - October 25 at 10:59 AM
marketrealist.com logoReasons behind the Superior YTD Performance of the Vanguard PRIMECAP Fund (NYSE:LLY)
marketrealist.com - October 24 at 5:43 PM
News IconWhat to Look for When Eli Lilly Reports Earnings (NYSE:LLY)
feedproxy.google.com - October 24 at 1:20 PM
wallstrt24.com logoMomentum Stocks in Focus EnteroMedics Inc (NASDAQ:ETRM), Eli Lilly and Co (NYSE:LLY) - Wall Street 24 (NYSE:LLY)
wallstrt24.com - October 24 at 11:18 AM
News IconTwo Stable Stocks: Eli Lilly and Company (NYSE:LLY), Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) - The Newburgh Press (NYSE:LLY)
newburghpress.com - October 24 at 11:18 AM
marketrealist.com logoEli Lilly and Co.’s Valuation Cheat Sheet 3Q16 (NYSE:LLY)
marketrealist.com - October 24 at 11:18 AM
marketrealist.com logoAnalyst Recommendations for Pfizer and Its Peers in 2016 (NYSE:LLY)
marketrealist.com - October 24 at 11:18 AM
finance.yahoo.com logoDrug Stocks Q3 Earnings Roster for Oct 25: MRK, LLY & More (NYSE:LLY)
finance.yahoo.com - October 24 at 11:18 AM
marketwatch.com logoAre The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments - MarketWatch (NYSE:LLY)
www.marketwatch.com - October 23 at 5:47 PM
News IconWorth Watching Stock: Eli Lilly and Company (NYSE:LLY) (NYSE:LLY)
avauncer.com - October 23 at 10:17 AM
prnewswire.com logoFDA Approves Lilly's LARTRUVO™ (olaratumab) in Combination with Doxorubicin for Soft Tissue Sarcoma - PR Newswire (press release) (NYSE:LLY)
www.prnewswire.com - October 21 at 5:57 PM
forbes.com logoEarnings: Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments (NYSE:LLY)
www.forbes.com - October 21 at 11:40 AM
reuters.com logoFDA grants accelerated approval to Lilly's soft tissue sarcoma drug - Reuters (NYSE:LLY)
www.reuters.com - October 21 at 9:20 AM
foxnews.com logoLilly's soft tissue sarcoma treatment gets US approval (NYSE:LLY)
www.foxnews.com - October 20 at 11:38 AM
News IconLilly cancer drug lands accelerated FDA approval (NYSE:LLY)
www.ibj.com - October 20 at 11:38 AM
4-traders.com logoEli Lilly and Co : quaterly earnings release (NYSE:LLY)
www.4-traders.com - October 20 at 11:38 AM
reuters.com logoFDA grants accelerated approval to Lilly's soft tissue sarcoma drug (NYSE:LLY)
in.reuters.com - October 20 at 11:38 AM
News IconEli Lilly and Company Launches $90 Million Global Health Partnership (NYSE:LLY)
philanthropynewsdigest.org - October 20 at 11:38 AM
reuters.com logoLilly's soft tissue sarcoma treatment gets U.S. approval (NYSE:LLY)
www.reuters.com - October 19 at 6:16 PM
publicnow.com logoFDA Approves Lilly's LARTRUVO™ (olaratumab) in Combination with Doxorubicin for Soft Tissue Sarcoma (NYSE:LLY)
www.publicnow.com - October 19 at 6:16 PM
4-traders.com logoEli Lilly and : Lilly plans $90 million investment to improve health care in poor areas (NYSE:LLY)
www.4-traders.com - October 19 at 10:53 AM
News IconEli Lilly and Company's (LLY): Stock's Report of the Friday (NYSE:LLY)
www.perspectivabetica.com - October 19 at 10:53 AM
News IconEli Lilly and Company announces plan to increase access to health care worldwide (NYSE:LLY)
www.theindychannel.com - October 19 at 10:53 AM
News IconLilly Launches $90M Global Initiative (NYSE:LLY)
www.insideindianabusiness.com - October 19 at 10:53 AM
marketrealist.com logoEli Lilly and Co.’s 3Q16 Estimates: Expectations for New Products (NYSE:LLY)
marketrealist.com - October 19 at 10:53 AM
News IconHistory of Eli Lilly and Company (NYSE:LLY) stock price after earnings (NYSE:LLY)
myhealthbowl.com - October 19 at 10:53 AM
News IconTop Gainers of the Day: Eli Lilly and Company (NYSE:LLY) from Drug Manufacturers – Major (NYSE:LLY)
twincountynews.com - October 19 at 10:53 AM
News IconLilly plans $90 million investment to improve health care in poor areas (NYSE:LLY)
www.indystar.com - October 19 at 10:53 AM
finance.yahoo.com logoCan Eli Lilly (LLY) Pull a Surprise this Earnings Season? (NYSE:LLY)
finance.yahoo.com - October 19 at 10:53 AM
247wallst.com logoMerrill Lynch Makes a Big New Addition to the US 1 List (NYSE:LLY)
247wallst.com - October 19 at 10:53 AM
marketrealist.com logoEli Lilly and Co.’s 3Q16 Estimates: Endocrine Franchise (NYSE:LLY)
marketrealist.com - October 19 at 10:53 AM
News Icon2 Stocks Analyst-Opinion Need Close Attention: Pioneer Natural Resources Co. (NYSE:PXD), Eli Lilly and Company ... - The Voice Registrar (NYSE:LLY)
voiceregistrar.com - October 18 at 5:52 PM
finance.yahoo.com logoEli Lily Leaps Over Patent Hurdles (NYSE:LLY)
finance.yahoo.com - October 18 at 5:51 PM
marketrealist.com logoEli Lilly’s 3Q16 Earnings: What to Expect (NYSE:LLY)
marketrealist.com - October 18 at 5:51 PM
News IconEli Lilly plans $90 million investment to improve health care in poor areas - Indianapolis Star (NYSE:LLY)
www.indystar.com - October 18 at 11:08 AM
finance.yahoo.com logoLilly Announces Ambitious New Commitment to Expand Global Access to Health Care (NYSE:LLY)
finance.yahoo.com - October 18 at 11:08 AM
4-traders.com logoEli Lilly and : Lilly Declares Fourth-Quarter 2016 Dividend (NYSE:LLY)
www.4-traders.com - October 17 at 5:51 PM


Eli Lilly and (NYSE:LLY) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by MarketBeat.com Staff